ATC Group: N01BB02 Lidocaine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01BB02 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01B Anesthetics, local
4 N01BB Amides
5 N01BB02 Lidocaine

Active ingredients in N01BB02

Active Ingredient

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.

Related product monographs

Document Type Information Source  
 CATHEJELL Jelly in collapsible syringe MPI, CA: SPM Health Products and Food Branch (CA)
 LIDBREE Intrauterine gel MPI, EU: SmPC Health Products Regulatory Authority (IE)
 XYLOCAINE Spray MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ZINGO Powder intradermal injection MPI, US: SPL/PLR FDA, National Drug Code (US)

United States medicines

Medicines classified under this ATC code globally

Austria (AT)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.